Blackstone Inc.
BX
$117.04
-0.72%
Blackstone Inc. is the world's largest alternative asset manager, overseeing a vast portfolio that includes private equity, real estate, credit, and other alternative investments. The firm's distinct competitive identity is built on its unparalleled scale, with over $1.2 trillion in total assets under management, and its diversified platform serving both institutional and high-net-worth clients. The current investor narrative is dominated by the firm's strategic capital rotation, as evidenced by recent large-scale portfolio sales and acquisitions, alongside broader sector concerns regarding liquidity and fundraising in a challenging macroeconomic environment for private markets.…
BX
Blackstone Inc.
$117.04
Related headlines
Investment Opinion: Should I buy BX Today?
Rating: Hold. The core thesis is that Blackstone's formidable fundamentals are currently overshadowed by severe technical damage and sector headwinds, creating a high-risk, high-potential-reward scenario that favors patience over immediate conviction.
Supporting evidence includes a reasonable forward P/E of 15.7x based on projected EPS of $9.49, suggesting the market has priced in a recovery. The company's scale ($1.2T AUM), profitability (34.8% ROE), and cash generation ($3.48B TTM FCF) are best-in-class. However, these are counterbalanced by the stock's severe underperformance (-44.9% vs. SPY), high volatility (beta 1.63), and concerning margin compression in the latest quarter.
The thesis would upgrade to a Buy on a sustained technical reversal above the downtrend line, confirmation of the $9.49+ EPS trajectory in upcoming quarters, or a decline to the $105-$110 range offering a larger margin of safety. It would downgrade to a Sell if the stock breaks decisively below the $101.73 support level, if forward EPS estimates are materially cut, or if quarterly gross margins fail to stabilize above 70%. Relative to its own history and the projected earnings recovery, the stock appears fairly valued to slightly undervalued, but the high uncertainty warrants a Hold rating.
Sign up to view all
BX 12-Month Price Forecast
The investment case for BX is a classic clash between deteriorating price momentum and still-strong underlying fundamentals. The neutral stance reflects the high uncertainty in the outcome. The path of forward earnings is the linchpin; confirmation would make the current price a bargain, while a miss would justify further declines. The stance would upgrade to bullish on a confirmed breakout above $130 with volume, signaling the downtrend has broken. It would turn bearish on a weekly close below $101, opening the door to a test of the max drawdown lows.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Blackstone Inc.'s 12-month outlook, with a consensus price target around $152.15 and implied upside of +30.0% versus the current price.
Average Target
$152.15
1 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
1
covering this stock
Price Range
$94 - $152
Analyst target range
Insufficient analyst coverage available. The provided data indicates only one analyst, which is atypical for a firm of Blackstone's size and prominence and may reflect a data gap. Limited coverage can lead to higher volatility and less efficient price discovery, as the stock may not benefit from the constant scrutiny and valuation benchmarks provided by a broad analyst community. The available data from that single analyst points to an estimated EPS of $9.49 for the coming period, which, if achieved, would support a significantly lower forward PE multiple. The institutional ratings data shows recent actions from firms like BMO Capital (Outperform), Barclays (Equal Weight), and UBS (Neutral), indicating a mixed but generally neutral-to-cautiously optimistic stance among those who do cover the stock, with no major downgrades in the recent period.
Bulls vs Bears: BX Investment Factors
The evidence is currently balanced but tilts bearish due to the powerful and persistent technical downtrend overwhelming otherwise strong fundamentals. The bull case is built on a compelling valuation reset (15.7x forward P/E), world-class scale, and robust profitability. The bear case is driven by severe price action, high volatility, and sector headwinds. The single most important tension in the investment debate is whether the market's forward earnings expectations of $9.49 EPS are achievable. If Blackstone can deliver on this projected earnings recovery, the stock is deeply undervalued. If the macro environment continues to suppress realizations and fundraising, the forward estimates will prove too optimistic, and the downtrend will persist.
Bullish
- Strong Forward Earnings Growth: The forward P/E of 15.7x is less than half the trailing P/E of 39.9x, indicating analysts expect a significant earnings recovery. The single analyst estimate points to an EPS of $9.49, which would represent a massive increase from the current trailing EPS of $0.025.
- Dominant Scale and Diversified Platform: With over $1.2 trillion in total AUM and a diversified portfolio across private equity, real estate, credit, and insurance, Blackstone possesses an unparalleled competitive moat. This scale provides significant fee-earning stability, with $921.7 billion in fee-earning AUM.
- Robust Profitability and Cash Generation: The company maintains high profitability with a trailing net margin of 21.8% and an exceptional ROE of 34.8%. It also generates substantial free cash flow, with TTM FCF of $3.48 billion, supporting capital returns and operational flexibility.
- Deeply Oversold Technical Condition: Trading at $117.89, the stock is near the lower end of its 52-week range ($101.73-$190.09), sitting at approximately 17% of the range's span. This suggests the severe 1-year decline of -19.7% may have created a value opportunity, though the downtrend remains intact.
Bearish
- Severe and Sustained Price Downtrend: The stock is down 25.8% YTD and 19.7% over the past year, underperforming the SPY by 44.9%. Recent momentum remains weak, with a 9.4% decline over the past month, indicating persistent selling pressure and a lack of positive catalysts.
- High Volatility and Market Sensitivity: A beta of 1.634 means BX is over 60% more volatile than the broader market. This high volatility has contributed to a maximum drawdown of -45.9% and makes the stock highly sensitive to shifts in market sentiment towards growth and financials.
- Lumpy and Declining Quarterly Performance: While Q4 2025 revenue grew 54.7% YoY, it declined sequentially from Q2 2025's $3.71B. More concerning is the gross margin compression to 64.5% in Q4 from over 96% in prior quarters, indicating a shift to lower-margin revenue streams.
- Sector-Wide Liquidity and Fundraising Concerns: News of peers like Blue Owl capping redemptions signals potential liquidity stress in the private credit sector. A challenging macro environment for private markets could pressure fundraising and limit future fee-earning AUM growth.
BX Technical Analysis
The stock is in a pronounced and sustained downtrend, evidenced by a 1-year price change of -19.67% and a year-to-date decline of -25.76%. Currently trading at $117.89, the price sits near the lower end of its 52-week range of $101.73 to $190.09, positioning it at approximately 17% of the range's span, which suggests the stock is deeply oversold and may present a value opportunity, though it remains a 'falling knife' within the prevailing bearish trend. Recent momentum shows continued weakness, with the stock down 9.45% over the past month and 9.22% over the past three months, aligning with and accelerating the longer-term downtrend rather than signaling a divergence. The stock's beta of 1.634 indicates it is over 60% more volatile than the broader market, which has contributed to its severe underperformance, as shown by a 1-year relative strength of -44.86% against the SPY. Key technical levels are clearly defined, with the 52-week low of $101.73 acting as critical support and the 52-week high of $190.09 representing formidable resistance; a decisive breakdown below support could trigger another leg down, while a sustained move above the recent downtrend line would be the first sign of a potential reversal, though the high volatility necessitates careful risk management.
Beta
1.63
1.63x market volatility
Max Drawdown
-45.9%
Largest decline past year
52-Week Range
$102-$190
Price range past year
Annual Return
-20.2%
Cumulative gain past year
| Period | BX Return | S&P 500 |
|---|---|---|
| 1m | -9.3% | +4.0% |
| 3m | -10.9% | +8.2% |
| 6m | -15.6% | +11.5% |
| 1y | -20.2% | +24.3% |
| ytd | -26.3% | +8.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
BX Fundamental Analysis
Revenue growth has been exceptionally strong but volatile, with Q4 2025 revenue of $4.36 billion representing a massive 54.7% year-over-year increase. However, this follows a sequential decline from Q2 2025's $3.71 billion, indicating lumpy performance typical of the asset management business where realized gains can vary significantly by quarter. The Private Equity and Real Estate segments contributed $351.7 million and $229.5 million in the latest period, respectively, though specific growth rates are not available. The company is highly profitable, with Q4 2025 net income of $1.02 billion and a trailing net margin of 21.8%. Gross margin was 64.5% in Q4, a significant compression from the 96%+ levels seen in prior quarters of 2025, which is attributable to the mix of revenue, as fee-related earnings carry higher margins than investment income. Profitability metrics are robust, with a Return on Equity (ROE) of 34.8% and Return on Assets (ROA) of 13.0%, indicating efficient use of capital. The balance sheet shows moderate leverage with a debt-to-equity ratio of 1.54, and the company generates substantial cash flow, with trailing twelve-month free cash flow of $3.48 billion. However, operating cash flow was negative $3.1 million in Q4 2025 due to significant changes in working capital, highlighting the quarterly variability. The strong free cash flow generation supports the company's ability to fund operations and return capital to shareholders, as evidenced by the high ROE.
Quarterly Revenue
$4.4B
2025-12
Revenue YoY Growth
+0.54%
YoY Comparison
Gross Margin
+0.64%
Latest Quarter
Free Cash Flow
$3.5B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is BX Overvalued?
Given the positive net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. The trailing PE is 39.87x, while the forward PE is significantly lower at 15.67x, indicating the market expects a substantial earnings recovery in the coming year. This wide gap suggests current earnings are depressed, potentially due to lower realized gains, and that analysts project a normalization or growth in distributable earnings. Compared to its own historical range, the current trailing PE of 39.87x is above the levels seen in 2021 and early 2022 (which were often below 20x) but has moderated from peaks above 50x in 2023. This positioning suggests the stock is not at bargain-basement historical levels but has repriced from extreme optimism. Industry comparison data is not available in the provided dataset, preventing a direct sector premium/discount analysis. However, the forward PE of 15.7x appears reasonable for a market-leading asset manager if the projected earnings growth materializes, though it remains sensitive to capital markets activity and fundraising cycles.
PE
39.9x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range -549x~6765x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
27.1x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks center on earnings volatility and margin pressure. The Q4 gross margin compression from 96%+ to 64.5% is stark, driven by a revenue mix shift away from high-margin fee income. While TTM free cash flow is strong at $3.48B, quarterly operating cash flow was negative $3.1M in Q4, highlighting significant lumpiness. The debt-to-equity ratio of 1.54 indicates moderate leverage, but the business model is inherently cyclical, dependent on capital markets activity for lucrative exit events.
Market & Competitive Risks are elevated. The stock's high beta of 1.634 makes it a leveraged play on broader market sentiment, which has been punishing. Sector-wide concerns about liquidity, as evidenced by news of redemption caps at peers, could trigger outflows and compress fee-earning AUM growth. Furthermore, the stock trades at a trailing P/E of 39.9x, which, while down from peaks, is not cheap historically and remains vulnerable to multiple compression if growth expectations falter.
The Worst-Case Scenario involves a prolonged downturn in private market activity, leading to missed forward EPS estimates, declining AUM, and sustained outflows. This could trigger a re-rating to a distressed multiple. The realistic downside is significant; a retest of the 52-week low of $101.73 would represent a -14% decline from the current $117.89. In a severe bear case mirroring the stock's max drawdown of -45.9%, the price could fall towards the mid-$60s, implying a potential loss of over -40% from current levels.
FAQ
The key risks are, in order of severity: 1) Market & Sentiment Risk: The stock's high beta (1.63) makes it extremely sensitive to broader market swings and risk-off sentiment, as evidenced by its -44.9% relative performance. 2) Execution/Earnings Risk: The investment thesis hinges on achieving forward EPS of ~$9.49; a miss would lead to significant multiple compression. 3) Sector Risk: Liquidity concerns in private credit and a tough fundraising environment could pressure fee-earning AUM growth. 4) Operational Risk: The sharp gross margin compression in Q4 2025 (to 64.5% from >96%) needs to be monitored for permanence.
Our 12-month outlook presents three scenarios. The Base Case (50% probability) sees the stock trading between $130 and $150 as it delivers on forward EPS estimates and consolidates. The Bull Case (30% probability) projects a rally to $170-$190 on a strong earnings recovery and improved sector sentiment. The Bear Case (20% probability) warns of a decline to $95-$110 if macro headwinds worsen and earnings estimates are cut. The most likely outcome is the Base Case, which assumes the company navigates current challenges without a major stumble, allowing the stock to recover modestly from deeply oversold levels as volatility subsides.
The valuation picture is split. Based on trailing earnings (P/E of 39.9x), the stock appears expensive. However, the market is clearly looking forward, with a forward P/E of 15.7x based on an estimated EPS of $9.49. This forward multiple appears reasonable for a market-leading asset manager if those earnings materialize. Compared to its own history, the stock has repriced significantly from peak optimism. The current valuation implies the market is pricing in a successful earnings recovery but remains skeptical, assigning a discount due to macro and sector risks. On a forward basis, it is fairly valued to slightly undervalued, but this is entirely contingent on hitting future earnings targets.
BX presents a high-risk, high-reward opportunity that is not suitable for all investors. For a patient, long-term investor comfortable with volatility, the current price offers a reasonable entry point to own a best-in-class franchise, with a forward P/E of 15.7x suggesting the market expects an earnings recovery. However, the severe downtrend (-19.7% over 1 year) and sector headwinds mean it is a 'falling knife' scenario. It could be a good buy for a speculative portion of a portfolio, but investors should be prepared for further downside, potentially to the $101 support level, before a sustained recovery begins.
BX is unequivocally a long-term investment, requiring a minimum horizon of 3-5 years. The business model is cyclical, and the stock's high beta (1.63) makes it unsuitable for short-term trading without sophisticated risk management. The current investment thesis is based on a multi-quarter earnings recovery story, not a quick technical bounce. Furthermore, the company does not offer a meaningful dividend yield (0.05%) for income-focused holders. This stock is best suited for growth-oriented portfolios that can absorb its high volatility while waiting for the fundamental cycle to turn.
